Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × schizandrin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 1

Interventions

Cyclophosphamide 2781 Cisplatin 2762 Carboplatin 2561 Radiotherapy 2361 Paclitaxel 2346 Gemcitabine 2212 pembrolizumab 2033 Docetaxel 1919 Bevacizumab 1871 Fluorouracil 1613 Capecitabine 1580 Oxaliplatin 1500 Dexamethasone 1388 Nivolumab 1316 Doxorubicin 1302 Rituximab 1287 Etoposide 1184 Magnetic Resonance Spectroscopy 1103 Irinotecan 1092 Leucovorin 1071 Cytarabine 996 Drug Therapy 929 fludarabine 920 Pemetrexed 917 Vincristine 830 Prednisone 819 Lenalidomide 813 Cetuximab 799 Specimen Handling 797 Filgrastim 793

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06214195 2024-01-19

START

Zhejiang Cancer Hospital

Phase 3 Recruiting

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡